Neaga, I.-O., Hambye, S., Bodoki, E., Blankert, B., & Oprean, R. (13 September 2017). Affinity capillary electrophoresis as fast screening method for oligonucleotides-ligands interaction assessment to identify potentially active compounds in myotonic dystrophy type 1 [Paper presentation]. EDT Scieces pharmaceutiques : PHD Day, Spa, Belgium. |
Neaga, I.-O., Hambye, S., Bodoki, E., Ansseau, E., Blankert, B., & Oprean, R. (22 May 2017). Affinity capillary electrophoresis as fast screening method for the identification of potentially active compounds for DM1 treatment [Poster presentation]. The 45th International Symposium on High Performance Liquid Phase Separations and Related Techniques, Prague, Czechia. |
Neaga, I.-O., Hambye, S., Palmieri, C., Bodoki, E., Blankert, B., & Oprean, R. (07 March 2017). Screening of nucleic acid acting drugs by capillary electrophoresis. Applications in myotonic dystrophy type 1 [Poster presentation]. MDC : Mardi des Chercheurs 2017, Mons, Belgium. |
  | Neaga, I.-O., Bodoki, E., Hambye, S., Blankert, B., & Oprean, R. (28 October 2016). Study of nucleic acid-ligand interactions by capillary electrophoretic techniques: A review. Talanta, 148, 247-256.  Peer reviewed vérifié par ORBi |
Neaga, I.-O., Hambye, S., Bodoki, E., Blankert, B., & Oprean, R. (17 October 2016). STUDY OF OLIGONUCLEOTIDES-LIGAND INTERACTIONS BY CAPILLARY ELECTROPHORESIS TECHNIQUES. APPLICATIONS IN MYOTONIC DYSTROPHY TYPE 1 [Paper presentation]. 19th Forum of Pharmaceutical Sciences, Bruxelles, Belgium. |
Neaga, I.-O., Bodoki, E., Hambye, S., Blankert, B., & Oprean, R. (06 July 2016). Characterization of oligonucleotides-ligand interactions with implications in myotonic dystrophy [Paper presentation]. 16th CEEPUS Symposium and Summer School on Bioanalysis, Warsaw, Unknown/unspecified. Peer reviewed |
Hambye, S., Neaga, I.-O., Carminati, A., Ansseau, E., Vanden Eynde, J.-J., Bodoki, E., Sandulescu, R., Belayew, A., & Blankert, B. (01 June 2013). Study of nucleic acids-ligands interactions by two different strategies. Application to Myotonic Dystrophy type 1 [Poster presentation]. Health Institute Day, Mons, Umons, Belgium. |